Table 4.
Vi-DT Group |
Placebo Group |
||||||
---|---|---|---|---|---|---|---|
Within 7 days after first dose | N | Number of participants (%) | 95% CI | N | Number of participants (%) | 95% CI | P-value |
All ages | 228 | 59 (25.88%) | (20.63, 31.93) | 57 | 11 (19.30%) | (11.13, 31.34) | 0.295 |
6 to < 9 month | 76 | 17 (22.37%) | (14.46, 32.93) | 19 | 4 (21.05%) | (8.51, 43.33) | – |
9 to 12 months | 76 | 29 (38.16%) | (28.06, 49.40) | 19 | 5 (26.32%) | (11.81 , 48.79) | – |
13 to 23 months | 76 | 13 (17.11%) | (10.28, 27.10) | 19 | 2 (10.53%) | (2.94 , 31.39) | – |